Clorox (CLX)
(Real Time Quote from BATS)
$162.95 USD
+0.25 (0.15%)
Updated Nov 7, 2024 01:40 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Balance Sheet
Fiscal Year End for The Clorox Company falls in the month of June.
All items in Millions except Per Share data.
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 202 | 367 | 183 | 319 | 871 |
Receivables | 695 | 688 | 681 | 604 | 648 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 637 | 696 | 755 | 752 | 454 |
Other Current Assets | 88 | 77 | 106 | 154 | 47 |
Total Current Assets | 1,622 | 1,828 | 1,725 | 1,829 | 2,020 |
Net Property & Equipment | 1,315 | 1,345 | 1,334 | 1,302 | 1,103 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,909 | 1,964 | 2,442 | 2,493 | 2,471 |
Deposits & Other Assets | 545 | 462 | 315 | 378 | 328 |
Total Assets | 5,751 | 5,945 | 6,158 | 6,334 | 6,213 |
Liabilities & Shareholders Equity | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 |
---|---|---|---|---|---|
Notes Payable | 4 | 50 | 237 | 0 | 0 |
Accounts Payable | 1,486 | 1,659 | 1,469 | 1,675 | 1,329 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 300 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 121 | 0 | 0 | 25 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,574 | 1,917 | 1,784 | 2,056 | 1,418 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 22 | 28 | 66 | 67 | 62 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,481 | 2,477 | 2,474 | 2,484 | 2,780 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 848 | 825 | 791 | 834 | 767 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 5,259 | 5,557 | 5,429 | 5,742 | 5,305 |
Shareholders Equity | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 131 | 131 | 131 | 131 | 159 |
Capital Surplus | 1,288 | 1,245 | 1,202 | 1,186 | 1,137 |
Retained Earnings | 250 | 583 | 1,048 | 1,036 | 3,567 |
Other Equity | 9 | -325 | -306 | -365 | -640 |
Treasury Stock | 1,186 | 1,246 | 1,346 | 1,396 | 3,315 |
Total Shareholder's Equity | 492 | 388 | 729 | 592 | 908 |
Total Liabilities & Shareholder's Equity | 5,751 | 5,945 | 6,158 | 6,334 | 6,213 |
Total Common Equity | 492 | 388 | 729 | 592 | 908 |
Shares Outstanding | 123.80 | 123.80 | 123.10 | 122.80 | 126.20 |
Book Value Per Share | 3.97 | 3.13 | 5.92 | 4.82 | 7.19 |
Fiscal Year End for The Clorox Company falls in the month of June.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 278 | 202 | 219 | 355 | 518 |
Receivables | 595 | 695 | 673 | 679 | 581 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 594 | 637 | 674 | 655 | 710 |
Other Current Assets | 109 | 88 | 95 | 115 | 102 |
Total Current Assets | 1,576 | 1,622 | 1,661 | 1,804 | 1,911 |
Net Property & Equipment | 1,242 | 1,315 | 1,292 | 1,314 | 1,317 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,814 | 1,909 | 1,917 | 1,950 | 1,949 |
Deposits & Other Assets | 524 | 545 | 556 | 486 | 486 |
Total Assets | 5,497 | 5,751 | 5,805 | 5,908 | 5,991 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | 4 | 4 | 111 | 247 | 347 |
Accounts Payable | 1,472 | 1,486 | 1,653 | 1,649 | 1,678 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 20 | 0 | 0 | 34 | 115 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,579 | 1,574 | 1,846 | 2,022 | 2,228 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 23 | 22 | 24 | 26 | 27 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,482 | 2,481 | 2,480 | 2,479 | 2,478 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 874 | 853 | 852 | 837 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 5,273 | 5,259 | 5,550 | 5,690 | 5,860 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 131 | 131 | 131 | 131 | 131 |
Capital Surplus | 1,297 | 1,288 | 1,270 | 1,245 | 1,246 |
Retained Earnings | 31 | 250 | 34 | 241 | 299 |
Other Equity | 17 | 9 | 9 | -194 | -326 |
Treasury Stock | 1,252 | 1,186 | 1,189 | 1,205 | 1,219 |
Total Shareholder's Equity | 224 | 492 | 255 | 218 | 131 |
Total Liabilities & Shareholder's Equity | 5,497 | 5,751 | 5,805 | 5,908 | 5,991 |
Total Common Equity | 224 | 492 | 255 | 218 | 131 |
Shares Outstanding | 123.70 | 123.80 | 124.10 | 124.10 | 124.00 |
Book Value Per Share | 1.81 | 3.97 | 2.05 | 1.76 | 1.06 |